首站-论文投稿智能助手
典型文献
Neurotrophin receptors, gamma-secretase inhibitors, and neurodegeneration of basal forebrain cholinergic neurons
文献摘要:
The amyloid hypothesis of Alzhemer's disease (AD) postulates that the generation of amyloid-beta (Aβ) peptide from the amyloid precursor protein (APP) by the action of the γ-secretase complex is one of the principal causes of AD. This idea is supported by the identification of several hereditary mutations in the APP gene or in the PSEN1 and PSEN2 genes that encode Presenilin-1 and Presenilin-2, the catalytic component of the γ-secretase complex. The assumption at that time was that familial AD (FAD), mutations lead to a gain of function phenotype, increasing the ratio between the levels of the toxic Aβ1–42, and the less toxic Aβ1–40 peptide (Kuperstein et al., 2010). Actually, the ratio Aβ1–42/Aβ1–40 is the principal cause of the toxic effect as some FAD mutations in APP decrease the levels of Aβ1–40 without changing the total levels of Aβ1–42 (Ancolio et al., 1997). Pharmaceutical companies started the race to design new highly specific γ-secretase inhibitors (GSIs) with good pharmacological properties to jump into the clinic. The reduction of the circulating levels of Aβ1–42 in AD mouse models rapidly supported this approximation, and one of the lead compounds, Semagacestat (Lilly), entered the phase Ⅲ clinical trials. However, results were not as good as initially expected, and the appearance of several skin cancer problems and a reduction, rather than an improvement, in the cognitive performance of the patients lead the FDA to stop the clinical trials.
文献关键词:
作者姓名:
Mar?al Vilar
作者机构:
Instituto de Biomedicina de València del CSIC,València,Spain
引用格式:
[1]Mar?al Vilar-.Neurotrophin receptors, gamma-secretase inhibitors, and neurodegeneration of basal forebrain cholinergic neurons)[J].中国神经再生研究(英文版),2022(07):1493-1494
A类:
forebrain,Alzhemer,postulates,PSEN2,Presenilin,Kuperstein,Ancolio,GSIs,Semagacestat
B类:
Neurotrophin,receptors,gamma,secretase,inhibitors,neurodegeneration,basal,cholinergic,neurons,amyloid,hypothesis,disease,that,beta,peptide,from,precursor,protein,by,action,complex,principal,causes,This,idea,supported,identification,several,hereditary,mutations,PSEN1,genes,encode,catalytic,component,assumption,was,familial,FAD,lead,gain,function,phenotype,increasing,between,levels,toxic,less,Actually,effect,some,decrease,without,changing,total,Pharmaceutical,companies,started,race,design,new,highly,specific,good,pharmacological,properties,jump,into,reduction,circulating,mouse,models,rapidly,this,approximation,compounds,Lilly,entered,phase,clinical,trials,However,results,were,initially,expected,appearance,skin,cancer,problems,rather,than,improvement,cognitive,performance,patients,FDA,stop
AB值:
0.497615
相似文献
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1 α-XBP1 pathway
Yuliang GUO;Siyu SONG;Xiaoxiao DU;Li TIAN;Man ZHANG;Hongmin ZHOU;Zhonghua Klaus CHEN;Sheng CHANG-Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Key Laboratory of Organ Transplantation,Ministry of Education,NHC Key Laboratory of Organ Transplantation,Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China;Henan Key Laboratory of Digestive Organ Transplantation,Open and Key Laboratory of Hepatobiliary&Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities,Zhengzhou Key Laboratory of Hepatobiliary&Pancreatic Diseases and Organ Transplantation,Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang;Xi Jiao;Shuang Li;Huan Chen;Xin Wei;Chang Liu;Jifang Gong;Xiaotian Zhang;Xicheng Wang;Zhi Peng;Changsong Qi;Zhenghang Wang;Yanni Wang;Na Zhuo;Jianling Zou;Henghui Zhang;Jian Li;Lin Shen;Zhihao Lu-Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Gastric&Colorectal Surgery,The First Hospital of Jilin University,Changchun 130021,China;Genecast Precision Medicine Technology Institute,Beijing 100192,China;Life Sciences Institute,Zhejiang University,Hangzhou 310058,China;Institute of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies,neuronal death and cognitive impairments
Keliang Pang;Richeng Jiang;Wei Zhang;Zhengyi Yang;Lin-Lin Li;Makoto Shimozawa;Simone Tambaro;Johanna Mayer;Baogui Zhang;Man Li;Jiesi Wang;Hang Liu;Ailing Yang;Xi Chen;Jiazheng Liu;Bengt Winblad;Hua Han;Tianzi Jiang;Weiwen Wang;Per Nilsson;Wei Guo;Bai Lu-School of Pharmaceutical Sciences,IDG/McGovern Institute for Brain Research,Tsinghua University-Peking University Joint Center for Life Sciences,Tsinghua University,Beijing,China;R&D Center for the Diagnosis and Treatment of Major Brain Diseases,Research Institute of Tsinghua University in Shenzhen,Shenzhen,Guangdong,China;Beijing Tiantan Hospital,Advanced Innovation Center for Human Brain Protection,Capital Medical University,Beijing,China;Department of Neurobiology,Care Sciences and Society,Division of Neurogeriatrics,Center for Alzheimer Research,Karolinska Institutet,Stockholm,Sweden;Department of Otorhinolaryngology Head and Neck Surgery,The First Hospital of Jilin University,Changchun,China;CAS Key Laboratory of Mental Health,Institute of Psychology,Chinese Academy of Sciences,and Department of Psychology,University of Chinese Academy of Sciences,Beijing,China;Brainnetome Center,Institute of Automation,Chinese Academy of Sciences,Beijing,China;Research Center for Brain-inspired Intelligence,National Laboratory of Pattern Recognition,Institute of Automation,School of Future Technology,University of CAS,and CAS Center for Excellence in Brain Science and Intelligence Technology,Chinese Academy of Sciences,Shanghai,China;Theme Aging,Karolinska University Hospital,Huddinge,Sweden
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He;Xinxin Xiong;Han Yang;Dandan Li;Xuefei Liu;Shuo Li;Shuangye Liao;Siyu Chen;Xizhi Wen;Kuai Yu;Lingyi Fu;Xingjun Dong;Kaiyu Zhu;Xiaojun Xia;Tiebang Kang;Chaochao Bian;Xiang Li;Haiping Liu;Peirong Ding;Xiaoshi Zhang;Zhenjiang Liu;Wende Li;Zhixiang Zuo;Penghui Zhou-State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Laboratory Animals Monitoring Institute,Guangdong Key Laboratory of Laboratory Animals,Guangzhou,China;Guangzhou Finelmmune Biotechnology Co.,LTD,Guangzhou,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。